The Fibrin Patch Soft Tissue Study

Exclusion Criteria

• •Subjects with any intra-operative findings identified by the surgeon that may preclude conduct of the study procedure
• •Subject with TBS within an actively infected field
• •Bleeding site is in, around, or in proximity to foramina in bone, or areas of bony confine
• •Subjects with known intolerance to blood products or to one of the components of the study product
• •Subjects unwilling to receive blood products
• •Subjects with immunodeficiency diseases (including known HIV)
• •Subjects who are known, current alcohol and / or drug abusers
• •Subjects who have participated in another investigational drug or device research study within 30 days of enrollment
• •Female subjects who are pregnant or nursing